Basic Information
Basic information for MIR9-3HG-253-16aa-3
Peptide Name MIR9-3HG-253-16aa-3
Genome Position chr15:89396027-89396074[+]
Species Human
Peptide Sequence MLACPPPSPPVGPTPF
Peptide Length 16
Unique No (MIR9-3HG-201-16aa-2,MIR9-3HG-202-16aa,MIR9-3HG-203-16aa,MIR9-3HG-205-16aa-2,MIR9-3HG-212-16aa-2,MIR9-3HG-213-16aa-2,MIR9-3HG-214-16aa-3,MIR9-3HG-218-16aa-3,MIR9-3HG-219-16aa-3,MIR9-3HG-220-16aa-2,MIR9-3HG-221-16aa-2,MIR9-3HG-222-16aa-3,MIR9-3HG-224-16aa,MIR9-3HG-225-16aa,MIR9-3HG-226-16aa-1,MIR9-3HG-227-16aa-3,MIR9-3HG-229-16aa-2,MIR9-3HG-233-16aa-3,MIR9-3HG-241-16aa-3,MIR9-3HG-242-16aa,MIR9-3HG-244-16aa,MIR9-3HG-246-16aa-4,MIR9-3HG-247-16aa-2,MIR9-3HG-248-16aa,MIR9-3HG-249-16aa,MIR9-3HG-251-16aa-3,MIR9-3HG-252-16aa-3)
Grand Average of Hydropathicity 0.2438
Relative Molecular Mass 1878.2
Experimental Evidences 2:m6A,ribo
lncRNA ID/Name ENSG00000255571;MIR9-3HG
Transcript ID/Name ENST00000671447;MIR9-3HG-253
Transcript Length 4989
Coding Ability 0.47
DNA Sequence Corresponding to Peptide ATGCTGGCCTGCCCTCCACCCAGTCCCCCTGTGGGCCCCACTCCCTTC
Experimental Evidences
   m6A
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :